Talking 'Bout Degeneration
Claim This Podcastby Angela Young
Podcast Overview
<p>An in depth look at the treatments available for the eye condition Age related Macular Degenration (AMD), or lack of. It is also a personal journey for presenter and journalist Angela Young, who has the condition.</p>
Language
🇺🇲
Publishing Since
7/2/2024
Reach the team behind Talking 'Bout Degeneration
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
November 21, 2024
Episode 6 Round two of red light therapy and wrapping up!
Angela explores red light therapy round two, discovers advancements in eye injections replacement and dry AMD treatment options.
October 29, 2024
Bonus episode
Send us a textIt has been a long wait since episode 5 was released but Angela got some good news which she wanted to share before publishing episode 6 - so here it is!For information about red light therapy in the UK and where it will be offered next, contact Optegra:https://www.optegra.com/dry-amd-treatment/Executive producer is Vince Hunthttp://www.vincenthunt.co.uk/Music performed by Mike Udinhttps://www.facebook.com/mike.udin.9For information about red light therapy in the UK and wh...
August 27, 2024
Episode 5 - Photobiomodulation 24
Send us a textIn her quest for treatments for macular degeneration, Angela Young, former BBC News Editor who has the disease, goes to PBM 24, the conference on photobiomodulation. She interviews Dr Clark Tedford, the CEO of Lumithera, which makes the Valeda red light system. Join her at the Park Plaza Hotel in London!For information about red light therapy in the UK and where it will be offered next, contact Optegra:https://www.optegra.com/dry-amd-treatment/Executive producer is Vince Hunthtt...
7 total episodes available
Deep-dive analytics for Talking 'Bout Degeneration
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Talking 'Bout Degeneration?
<p>An in depth look at the treatments available for the eye condition Age related Macular Degenration (AMD), or lack of. It is also a personal journey for presenter and journalist Angela Young, who has the condition.</p> - How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.